Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hemato...
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases
About this item
Full title
Author / Creator
Ringdén, O , Remberger, M , Svenberg, P , Svahn, B-M , Dahllöf, G , Gustafsson, B , Hassan, Z , Omazic, B , Uzunel, M , Aschan, J , Barkholt, L , Winiarski, J , Ljungman, P and Mattsson, J
Publisher
Basingstoke: Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
Basingstoke: Nature Publishing Group
Subjects
More information
Scope and Contents
Contents
Fludarabine-based conditioning (FBC) was given to 24 patients and conventional myeloablative conditioning (MC) to 33 patients, most children, before hematopoietic stem cell transplantation (HSCT) for non-malignant diseases. The donors were human leukocyte antigen (HLA)-A, -B, -DRbeta1-identical related (33%) or unrelated (67%). In the FBC group, tw...
Alternative Titles
Full title
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_571548
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_571548
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/sj.bmt.1705602
